A new prospective study published in Menopause suggests that women with a longer reproductive span may experience slower cognitive decline later in life. Researchers analyzed over 14,000 participants from the long-running Nurses’ Health Study and tracked cognitive performance over eight years.
The findings add to growing interest in how hormonal history, menopause timing, and menopausal hormone therapy may influence brain health during aging.
Researchers wanted to understand whether lifetime exposure to estrogen may affect memory and cognition in older women. To do this, they looked at two major factors:
The research included 14,217 women from the Nurses’ Health Study, with an average age of 74.3 years at the start of cognitive testing.
Women with the longest reproductive span, around 41 to 46 years, showed better cognitive performance over time compared with women whose reproductive span was 33 years or less.
Researchers found a statistically significant trend suggesting that longer natural estrogen exposure may help preserve brain function as women age.
Women who reached menopause at an older age tended to have better cognitive outcomes. This supports previous theories that estrogen may play a role in maintaining neurological health.
Contrary to some expectations, menopausal hormone therapy was not associated with better cognitive aging.
In fact, women who used hormone therapy within the first 10 years after menopause showed signs of slightly faster cognitive decline in some measures.
Researchers did not find major associations between cognition and:
Estrogen has been studied for decades because it appears to support several brain functions, including:
As estrogen levels fall sharply during menopause, some scientists believe this hormonal shift may contribute to age-related memory decline.
This study supports the idea that a longer lifetime estrogen history may have long-term neurological benefits.
These findings do not mean that hormone therapy should be used to prevent dementia or memory loss. The researchers specifically found no clear cognitive benefit from menopausal hormone therapy.
Instead, the study points toward the importance of understanding a woman’s reproductive timeline as one possible factor in long-term brain health.
Women who experience early menopause may want to discuss overall health monitoring with their doctor, especially regarding cardiovascular, bone, and cognitive health.
Although this was a large and well-designed study, there are several limitations:
This research strengthens the case that reproductive aging and brain aging may be biologically connected. Natural hormonal exposure across life could influence how cognition changes in later years.
However, hormone therapy remains complex, and treatment decisions should focus on menopause symptoms, cardiovascular risk, bone health, and personal medical history rather than cognitive protection alone.
As dementia rates rise globally, understanding women-specific risk factors is increasingly important. This study highlights that reproductive history may be one piece of the puzzle.
While longer reproductive span was linked to better cognitive aging, hormone therapy did not appear to offer the same benefit.
Future research may help explain how hormones, menopause timing, genetics, and lifestyle work together to shape women’s brain health across the lifespan.
Juramt N, Kang JH, Wang DD, et al. Prospective study of reproductive span and menopausal hormone therapy and cognitive decline over 8 years in the Nurses’ Health Study. The Menopause Society journal Menopause, 2026.
This article is for educational and informational purposes only and does not provide medical advice. It should not replace consultation with a qualified healthcare professional. Always speak with your doctor before making decisions about menopause treatment, hormone therapy, or memory concerns.
Most Accurate Healthcare AI designed for everything from admin workflows to clinical decision support.